TY - JOUR
T1 - Non-tuberculous mycobacterial infections in patients with end-stage renal disease
T2 - prevalence, risk factors, and mortality
AU - Toth, Eszter
AU - Waller, Jennifer L.
AU - Bollag, Wendy B.
AU - Siddiqui, Budder
AU - Mohammed, Azeem
AU - Kheda, Mufaddal
AU - Padala, Sandeep
AU - Young, Lufei
AU - Baer, Stephanie L.
AU - Tran, Sarah
N1 - Funding Information:
This work was supported in part by the Translational Research Program of the Medical College of Georgia Department of Medicine. Support for research time was provided by the Charlie Norwood VA Medical Center (SLB). The data reported here have been supplied by the United States Renal Data System.
Publisher Copyright:
© American Federation for Medical Research 2022. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022/10/6
Y1 - 2022/10/6
N2 - Non-tuberculous mycobacterial (NTM) disease has increased in prevalence in the USA, however, little is known on NTM in the population with end-stage renal disease (ESRD). Thus, we investigated patients with ESRD to determine risk factors for NTM disease and mortality. We queried the United States Renal Data System from 2005 to 2015 using International Classification of Diseases (ICD)-9/ICD-10 codes to identify NTM and risk factors. Logistic regression was used to examine the association of risk factors with NTM and Cox proportional hazards modeling was used to assess the association of NTM with mortality. Of 1,068,634 included subjects, 3232 (0.3%) individuals were identified with any NTM diagnosis. Hemodialysis versus peritoneal dialysis (OR=0.10, 95% CI=0.08 to 0.13) was protective for NTM, whereas black (OR=1.27, 95% CI=1.18 to 1.37) or other race compared with white race (OR=1.39, 95% CI=1.21 to 1.59) increased the risk of NTM. HIV (OR=15.71, 95% CI=14.24 to 17.33), history of any transplant (OR=4.25, 95% CI=3.93 to 4.60), kidney transplant (OR=3.00, 95% CI=2.75 to 3.27), diabetes (OR=1.32, 95% CI=1.23 to 1.43), rheumatologic disease (OR=1.92, 95% CI=1.77 to 2.08), and liver disease (OR=2.09, 95% CI=1.91 to 2.30) were associated with increased risk for NTM diagnosis. In multivariable analysis, there was a significant increase in mortality with any NTM diagnosis (HR=1.83, 95% CI=1.76 to 1.91, p≤0.0001). Controlling for relevant demographic and clinical risk factors, there was an increased risk of mortality associated with any diagnosis of NTM. Early diagnosis and treatment of NTM infection may improve survival in patients with ESRD.
AB - Non-tuberculous mycobacterial (NTM) disease has increased in prevalence in the USA, however, little is known on NTM in the population with end-stage renal disease (ESRD). Thus, we investigated patients with ESRD to determine risk factors for NTM disease and mortality. We queried the United States Renal Data System from 2005 to 2015 using International Classification of Diseases (ICD)-9/ICD-10 codes to identify NTM and risk factors. Logistic regression was used to examine the association of risk factors with NTM and Cox proportional hazards modeling was used to assess the association of NTM with mortality. Of 1,068,634 included subjects, 3232 (0.3%) individuals were identified with any NTM diagnosis. Hemodialysis versus peritoneal dialysis (OR=0.10, 95% CI=0.08 to 0.13) was protective for NTM, whereas black (OR=1.27, 95% CI=1.18 to 1.37) or other race compared with white race (OR=1.39, 95% CI=1.21 to 1.59) increased the risk of NTM. HIV (OR=15.71, 95% CI=14.24 to 17.33), history of any transplant (OR=4.25, 95% CI=3.93 to 4.60), kidney transplant (OR=3.00, 95% CI=2.75 to 3.27), diabetes (OR=1.32, 95% CI=1.23 to 1.43), rheumatologic disease (OR=1.92, 95% CI=1.77 to 2.08), and liver disease (OR=2.09, 95% CI=1.91 to 2.30) were associated with increased risk for NTM diagnosis. In multivariable analysis, there was a significant increase in mortality with any NTM diagnosis (HR=1.83, 95% CI=1.76 to 1.91, p≤0.0001). Controlling for relevant demographic and clinical risk factors, there was an increased risk of mortality associated with any diagnosis of NTM. Early diagnosis and treatment of NTM infection may improve survival in patients with ESRD.
KW - bacterial infections
KW - kidney failure, chronic
KW - kidney transplantation
KW - United States
UR - http://www.scopus.com/inward/record.url?scp=85142519316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142519316&partnerID=8YFLogxK
U2 - 10.1136/jim-2022-002462
DO - 10.1136/jim-2022-002462
M3 - Article
C2 - 36202430
SN - 1081-5589
JO - Journal of investigative medicine : the official publication of the American Federation for Clinical Research
JF - Journal of investigative medicine : the official publication of the American Federation for Clinical Research
M1 - jim-2022-002462
ER -
